{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:02:06Z","timestamp":1783576926498,"version":"3.55.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Intraclonal subpopulations of circulating chronic lymphocytic leukemia (CLL) cells with different proliferative histories and reciprocal surface expression of CXCR4 and CD5 have been observed in the peripheral blood of CLL patients and named proliferative (PF), intermediate (IF), and resting (RF) cellular fractions. Here, we found that these intraclonal circulating fractions share persistent DNA methylation signatures largely associated with the mutation status of the immunoglobulin heavy chain locus (IGHV) and their origins from distinct stages of differentiation of antigen-experienced B cells. Increased leukemic birth rate, however, showed a very limited impact on DNA methylation of circulating CLL fractions independent of IGHV mutation status. Additionally, DNA methylation heterogeneity increased as leukemic cells advanced from PF to RF in the peripheral blood. This frequently co-occurred with heterochromatin hypomethylation and hypermethylation of Polycomb-repressed regions in the PF, suggesting accumulation of longevity-associated epigenetic features in recently born cells. On the other hand, transcriptional differences between paired intraclonal fractions confirmed their proliferative experience and further supported a linear advancement from PF to RF in the peripheral blood. Several of these differentially expressed genes showed unique associations with clinical outcome not evident in the bulk clone, supporting the pathological and therapeutic relevance of studying intraclonal CLL fractions. We conclude that independent methylation and transcriptional landscapes reflect both preexisting cell-of-origin fingerprints and more recently acquired hallmarks associated with the life cycle of circulating CLL cells.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019000817","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T15:50:13Z","timestamp":1583769013000},"page":"893-905","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-8591","authenticated-orcid":false,"given":"Boris A.","family":"Bartholdy","sequence":"first","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiahoua","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jie","family":"Yan","sequence":"first","affiliation":[{"name":"The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1678-1054","authenticated-orcid":false,"given":"Mari\u00e9n","family":"Pascual","sequence":"first","affiliation":[{"name":"Hemato-Oncology Program, Cima Universidad de Navarra, Pamplona, Spain;"},{"name":"Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxia","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Barrientos","sequence":"first","affiliation":[{"name":"The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY;"},{"name":"Department of Medicine, Zucker School of Medicine at Hofstra\/Northwell, Manhasset, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Allen","sequence":"first","affiliation":[{"name":"The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY;"},{"name":"Department of Medicine, Zucker School of Medicine at Hofstra\/Northwell, Manhasset, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Angel","family":"Martinez-Climent","sequence":"first","affiliation":[{"name":"Hemato-Oncology Program, Cima Universidad de Navarra, Pamplona, Spain;"},{"name":"Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanti R.","family":"Rai","sequence":"first","affiliation":[{"name":"The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY;"},{"name":"Department of Medicine, Zucker School of Medicine at Hofstra\/Northwell, Manhasset, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1023-6650","authenticated-orcid":false,"given":"Nicholas","family":"Chiorazzi","sequence":"first","affiliation":[{"name":"The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY;"},{"name":"Department of Medicine, Zucker School of Medicine at Hofstra\/Northwell, Manhasset, NY; and"},{"name":"Department of Molecular Medicine, Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0368-2433","authenticated-orcid":false,"given":"Matthew D.","family":"Scharff","sequence":"first","affiliation":[{"name":"Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-0715","authenticated-orcid":false,"given":"Sergio","family":"Roa","sequence":"first","affiliation":[{"name":"Hemato-Oncology Program, Cima Universidad de Navarra, Pamplona, Spain;"},{"name":"Navarra Institute for Health Research (IdiSNA), Pamplona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"issue":"8","key":"2020030912395312800_B1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"2020030912395312800_B2","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1038\/nrdp.2016.96","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2020030912395312800_B3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"issue":"1","key":"2020030912395312800_B4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"issue":"23","key":"2020030912395312800_B5","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2009-05-219634","article-title":"In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia","volume":"114","author":"Calissano","year":"2009","journal-title":"Blood"},{"issue":"11-12","key":"2020030912395312800_B6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2119\/molmed.2011.00360","article-title":"Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born\/divided and older\/quiescent cells","volume":"17","author":"Calissano","year":"2011","journal-title":"Mol Med"},{"issue":"1","key":"2020030912395312800_B7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2020030912395312800_B8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1400376","article-title":"Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia","volume":"371","author":"Byrd","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"2020030912395312800_B9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/leu.2015.316","article-title":"BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia","volume":"30","author":"Chen","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"2020030912395312800_B10","doi-asserted-by":"crossref","first-page":"e89904","DOI":"10.1172\/jci.insight.89904","article-title":"Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib","volume":"2","author":"Burger","year":"2017","journal-title":"JCI Insight"},{"issue":"8","key":"2020030912395312800_B11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"issue":"6","key":"2020030912395312800_B12","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2020030912395312800_B13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2020030912395312800_B14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.leu.2402537","article-title":"Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course","volume":"16","author":"Stilgenbauer","year":"2002","journal-title":"Leukemia"},{"issue":"7574","key":"2020030912395312800_B15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"7574","key":"2020030912395312800_B16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"2","key":"2020030912395312800_B17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1101\/gr.152132.112","article-title":"Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia","volume":"24","author":"Ferreira","year":"2014","journal-title":"Genome Res"},{"issue":"1","key":"2020030912395312800_B18","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1038\/ncomms11938","article-title":"Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks","volume":"7","author":"Rendeiro","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"2020030912395312800_B19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","article-title":"The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia","volume":"24","author":"Beekman","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"2020030912395312800_B20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat Genet"},{"key":"2020030912395312800_B21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcancer.2015.04.009","article-title":"The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia","volume":"34","author":"Sutton","year":"2015","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"2020030912395312800_B22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2015-02-585042","article-title":"Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia","volume":"126","author":"Gui\u00e8ze","year":"2015","journal-title":"Blood"},{"issue":"21","key":"2020030912395312800_B23","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2020030912395312800_B24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/leu.2014.252","article-title":"A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact","volume":"29","author":"Queir\u00f3s","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"2020030912395312800_B25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat Genet"},{"issue":"7","key":"2020030912395312800_B26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ng.3291","article-title":"Whole-genome fingerprint of the DNA methylome during human B cell differentiation","volume":"47","author":"Kulis","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"2020030912395312800_B27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"2020030912395312800_B28","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/leu.2017.34","article-title":"Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia","volume":"31","author":"Murphy","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"2020030912395312800_B29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/leu.2013.248","article-title":"Clonal evolution in hematological malignancies and therapeutic implications","volume":"28","author":"Landau","year":"2014","journal-title":"Leukemia"},{"issue":"14","key":"2020030912395312800_B30","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1200\/JCO.2008.16.7874","article-title":"Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression","volume":"26","author":"Shanafelt","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"2020030912395312800_B31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1158\/2159-8290.CD-13-0349","article-title":"Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia","volume":"4","author":"Oakes","year":"2014","journal-title":"Cancer Discov"},{"issue":"6","key":"2020030912395312800_B32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"issue":"4","key":"2020030912395312800_B33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ygeno.2011.07.007","article-title":"High density DNA methylation array with single CpG site resolution","volume":"98","author":"Bibikova","year":"2011","journal-title":"Genomics"},{"issue":"7345","key":"2020030912395312800_B34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature09906","article-title":"Mapping and analysis of chromatin state dynamics in nine human cell types","volume":"473","author":"Ernst","year":"2011","journal-title":"Nature"},{"issue":"10","key":"2020030912395312800_B35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2018-02-692970","article-title":"Insight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies","volume":"132","author":"Oakes","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020030912395312800_B36","doi-asserted-by":"crossref","first-page":"e1003137","DOI":"10.1371\/journal.pgen.1003137","article-title":"Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity","volume":"9","author":"De","year":"2013","journal-title":"PLoS Genet"},{"issue":"13","key":"2020030912395312800_B37","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2011-06-357996","article-title":"DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation","volume":"118","author":"Shaknovich","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2020030912395312800_B38","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1101\/gr.155473.113","article-title":"DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation","volume":"23","author":"Lai","year":"2013","journal-title":"Genome Res"},{"issue":"9","key":"2020030912395312800_B39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s13059-014-0465-4","article-title":"DiffVar: a new method for detecting differential variability with application to methylation in cancer and aging","volume":"15","author":"Phipson","year":"2014","journal-title":"Genome Biol"},{"issue":"10","key":"2020030912395312800_B40","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types [published correction appears in Genome Biol. 2015;16:96]","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol"},{"issue":"5","key":"2020030912395312800_B41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/intimm\/12.5.631","article-title":"Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development","volume":"12","author":"Solvason","year":"2000","journal-title":"Int Immunol"},{"issue":"11","key":"2020030912395312800_B42","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1349-7006.2011.02046.x","article-title":"Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"102","author":"Igawa","year":"2011","journal-title":"Cancer Sci"},{"issue":"6220","key":"2020030912395312800_B43","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"6","key":"2020030912395312800_B44","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/leu.2017.11","article-title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","volume":"31","author":"Herndon","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"2020030912395312800_B45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/leu.2012.245","article-title":"450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments","volume":"27","author":"Cahill","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2020030912395312800_B46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-017-02595-w","article-title":"AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis","volume":"9","author":"Teater","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"2020030912395312800_B47","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"1","key":"2020030912395312800_B48","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1038\/ncomms9866","article-title":"Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution","volume":"6","author":"Kasar","year":"2015","journal-title":"Nat Commun"},{"issue":"7463","key":"2020030912395312800_B49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer [published correction appears in Nature. 2013;502(7470):258]","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"2020030912395312800_B50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exphem.2016.09.010","article-title":"Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones","volume":"46","author":"Bashford-Rogers","year":"2016","journal-title":"Exp Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/5\/893\/1718471\/advancesadv2019000817.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/5\/893\/1718471\/advancesadv2019000817.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T16:40:17Z","timestamp":1583772017000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/5\/893\/452642\/CLL-intraclonal-fractions-exhibit-established-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000817","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]}}}